↓ Skip to main content

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?

Overview of attention for article published in Frontiers in Pharmacology, August 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
20 X users

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
199 Mendeley
Title
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Published in
Frontiers in Pharmacology, August 2020
DOI 10.3389/fphar.2020.01161
Pubmed ID
Authors

Inés Valencia, Concepción Peiró, Óscar Lorenzo, Carlos F. Sánchez-Ferrer, Jürgen Eckel, Tania Romacho

X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 199 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 199 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 28 14%
Researcher 22 11%
Student > Ph. D. Student 18 9%
Other 15 8%
Student > Master 15 8%
Other 27 14%
Unknown 74 37%
Readers by discipline Count As %
Medicine and Dentistry 50 25%
Biochemistry, Genetics and Molecular Biology 20 10%
Nursing and Health Professions 9 5%
Agricultural and Biological Sciences 9 5%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Other 22 11%
Unknown 81 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2023.
All research outputs
#2,570,241
of 25,732,188 outputs
Outputs from Frontiers in Pharmacology
#1,084
of 19,996 outputs
Outputs of similar age
#67,127
of 427,823 outputs
Outputs of similar age from Frontiers in Pharmacology
#44
of 443 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,996 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,823 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 443 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.